SE9703378D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9703378D0 SE9703378D0 SE9703378A SE9703378A SE9703378D0 SE 9703378 D0 SE9703378 D0 SE 9703378D0 SE 9703378 A SE9703378 A SE 9703378A SE 9703378 A SE9703378 A SE 9703378A SE 9703378 D0 SE9703378 D0 SE 9703378D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- cycloalkyl
- substituted
- enantiomers
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703378A SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
ZA987806A ZA987806B (en) | 1997-09-18 | 1998-08-27 | Substituted chroman derivatives |
JP2000511762A JP4002392B2 (ja) | 1997-09-18 | 1998-09-09 | 置換されたクロマン誘導体 |
KR1020007002824A KR20010024078A (ko) | 1997-09-18 | 1998-09-09 | 치환된 크로만 유도체 |
CN98811095A CN1278809A (zh) | 1997-09-18 | 1998-09-09 | 取代的苯并二氢吡喃衍生物 |
PL98339661A PL339661A1 (en) | 1997-09-18 | 1998-09-09 | Substituted derivatives of chromane |
TR2000/00737T TR200000737T2 (tr) | 1997-09-18 | 1998-09-09 | İkame edilmiş kroman türevleri. |
AT98944378T ATE255099T1 (de) | 1997-09-18 | 1998-09-09 | Substituierte chromanderivate |
CA002303926A CA2303926A1 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
SK287-2000A SK2872000A3 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
DE69820103T DE69820103T2 (de) | 1997-09-18 | 1998-09-09 | Substituierte chromanderivate |
HU0100276A HUP0100276A3 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives, process for their preparation and medicaments containing them |
EEP200000144A EE200000144A (et) | 1997-09-18 | 1998-09-09 | Asendatud kromaani derivaadid |
AU91933/98A AU9193398A (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
PCT/SE1998/001604 WO1999014213A1 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
US09/171,572 US6387899B1 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
BR9812239-8A BR9812239A (pt) | 1997-09-18 | 1998-09-09 | Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto |
IL13507498A IL135074A0 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
EP98944378A EP1025096B1 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
ARP980104637A AR016651A1 (es) | 1997-09-18 | 1998-09-17 | Derivados de 3,4-dihidro-2h-1-benzopirano substituidos con piperidinilo o piperazinilo, proceso para su preparacion, compuestos para su exclusivo uso endicho proceso, formulaciones farmaceuticas que comprenden dichos derivados y su uso para la elaboracion de un medicamento |
HR20000133A HRP20000133A2 (en) | 1997-09-18 | 2000-03-09 | Substituted chroman derivatives |
IS5403A IS5403A (is) | 1997-09-18 | 2000-03-14 | Útskiptar króman afleiður |
NO20001403A NO20001403L (no) | 1997-09-18 | 2000-03-17 | Substituerte kromanderivater |
US09/653,552 US6384225B1 (en) | 1997-09-18 | 2000-08-31 | Intermediates in the preparation of substituted chroman derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703378A SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9703378D0 true SE9703378D0 (sv) | 1997-09-18 |
Family
ID=20408298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9703378A SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
Country Status (23)
Country | Link |
---|---|
US (2) | US6387899B1 (tr) |
EP (1) | EP1025096B1 (tr) |
JP (1) | JP4002392B2 (tr) |
KR (1) | KR20010024078A (tr) |
CN (1) | CN1278809A (tr) |
AR (1) | AR016651A1 (tr) |
AT (1) | ATE255099T1 (tr) |
AU (1) | AU9193398A (tr) |
BR (1) | BR9812239A (tr) |
CA (1) | CA2303926A1 (tr) |
DE (1) | DE69820103T2 (tr) |
EE (1) | EE200000144A (tr) |
HR (1) | HRP20000133A2 (tr) |
HU (1) | HUP0100276A3 (tr) |
IL (1) | IL135074A0 (tr) |
IS (1) | IS5403A (tr) |
NO (1) | NO20001403L (tr) |
PL (1) | PL339661A1 (tr) |
SE (1) | SE9703378D0 (tr) |
SK (1) | SK2872000A3 (tr) |
TR (1) | TR200000737T2 (tr) |
WO (1) | WO1999014213A1 (tr) |
ZA (1) | ZA987806B (tr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
EP1353915A2 (en) * | 2001-01-16 | 2003-10-22 | AstraZeneca AB | Therapeutic chroman compounds |
IL156595A0 (en) | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
JP2004517129A (ja) | 2001-01-16 | 2004-06-10 | アストラゼネカ・アクチエボラーグ | 治療用クロモン化合物 |
WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
CA2453837C (en) * | 2001-07-20 | 2011-10-04 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds |
GB0124020D0 (en) * | 2001-10-05 | 2001-11-28 | Astrazeneca Ab | Chemical compounds |
ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
CA2580584C (en) | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
TWI346109B (en) * | 2004-04-30 | 2011-08-01 | Otsuka Pharma Co Ltd | 4-amino-5-cyanopyrimidine derivatives |
KR100681453B1 (ko) * | 2005-03-22 | 2007-02-12 | 태남자동화기기 주식회사 | 권종 분류 기능을 구비한 지폐 방출기 |
US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
WO2008130321A2 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain |
WO2008130319A2 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain |
SA08290245B1 (ar) | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم |
WO2008130323A1 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain |
WO2008130322A1 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel 5-heterocyclyl-chromane derivatives for the treatment of pain |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04504721A (ja) * | 1989-04-27 | 1992-08-20 | ジ・アップジョン・カンパニー | 置換3―アミノ・クロマン類 |
US5420151A (en) | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
WO1997007120A1 (en) * | 1995-08-11 | 1997-02-27 | Smithkline Beecham Plc | Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
-
1997
- 1997-09-18 SE SE9703378A patent/SE9703378D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987806A patent/ZA987806B/xx unknown
- 1998-09-09 AU AU91933/98A patent/AU9193398A/en not_active Abandoned
- 1998-09-09 PL PL98339661A patent/PL339661A1/xx not_active Application Discontinuation
- 1998-09-09 US US09/171,572 patent/US6387899B1/en not_active Expired - Fee Related
- 1998-09-09 EP EP98944378A patent/EP1025096B1/en not_active Expired - Lifetime
- 1998-09-09 BR BR9812239-8A patent/BR9812239A/pt not_active IP Right Cessation
- 1998-09-09 IL IL13507498A patent/IL135074A0/xx unknown
- 1998-09-09 CA CA002303926A patent/CA2303926A1/en not_active Abandoned
- 1998-09-09 DE DE69820103T patent/DE69820103T2/de not_active Expired - Fee Related
- 1998-09-09 CN CN98811095A patent/CN1278809A/zh active Pending
- 1998-09-09 EE EEP200000144A patent/EE200000144A/xx unknown
- 1998-09-09 AT AT98944378T patent/ATE255099T1/de not_active IP Right Cessation
- 1998-09-09 TR TR2000/00737T patent/TR200000737T2/tr unknown
- 1998-09-09 JP JP2000511762A patent/JP4002392B2/ja not_active Expired - Fee Related
- 1998-09-09 KR KR1020007002824A patent/KR20010024078A/ko not_active Application Discontinuation
- 1998-09-09 WO PCT/SE1998/001604 patent/WO1999014213A1/en active IP Right Grant
- 1998-09-09 HU HU0100276A patent/HUP0100276A3/hu unknown
- 1998-09-09 SK SK287-2000A patent/SK2872000A3/sk unknown
- 1998-09-17 AR ARP980104637A patent/AR016651A1/es not_active Application Discontinuation
-
2000
- 2000-03-09 HR HR20000133A patent/HRP20000133A2/hr not_active Application Discontinuation
- 2000-03-14 IS IS5403A patent/IS5403A/is unknown
- 2000-03-17 NO NO20001403A patent/NO20001403L/no not_active Application Discontinuation
- 2000-08-31 US US09/653,552 patent/US6384225B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1025096B1 (en) | 2003-11-26 |
PL339661A1 (en) | 2001-01-02 |
US6384225B1 (en) | 2002-05-07 |
NO20001403L (no) | 2000-05-18 |
EE200000144A (et) | 2001-02-15 |
EP1025096A1 (en) | 2000-08-09 |
IL135074A0 (en) | 2001-05-20 |
US6387899B1 (en) | 2002-05-14 |
NO20001403D0 (no) | 2000-03-17 |
CN1278809A (zh) | 2001-01-03 |
BR9812239A (pt) | 2000-07-18 |
HUP0100276A2 (hu) | 2002-05-29 |
CA2303926A1 (en) | 1999-03-25 |
SK2872000A3 (en) | 2000-11-07 |
AU9193398A (en) | 1999-04-05 |
IS5403A (is) | 2000-03-14 |
HRP20000133A2 (en) | 2001-12-31 |
AR016651A1 (es) | 2001-07-25 |
JP4002392B2 (ja) | 2007-10-31 |
ATE255099T1 (de) | 2003-12-15 |
HUP0100276A3 (en) | 2002-08-28 |
JP2001516755A (ja) | 2001-10-02 |
KR20010024078A (ko) | 2001-03-26 |
WO1999014213A1 (en) | 1999-03-25 |
TR200000737T2 (tr) | 2000-09-21 |
DE69820103T2 (de) | 2004-09-02 |
DE69820103D1 (de) | 2004-01-08 |
ZA987806B (en) | 1999-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9702799D0 (sv) | New compounds | |
SE9703378D0 (sv) | New compounds | |
SE9703377D0 (sv) | New compounds | |
NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
HUP0300527A2 (hu) | Pirrolopirimidinon-származékok, a vegyületek előállítása és alkalmazása | |
HUP0000591A2 (hu) | Fémproteáz inhibitor hatású piperazin-, morfolin- és tiomorfolin-származékok és alkalmazásuk gyógyszerkészítmények előállítására | |
HUP0300565A2 (hu) | PDE 5 inhibitor hatású 8-kinolin-xantin- és 8-izo-kinolin-xantin-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AR025975A1 (es) | Compuestos quimicos. | |
SE0101579D0 (sv) | New compounds | |
DK0649418T3 (da) | 7-(2-aminoethyl)benzothiazolon | |
CA1272482C (en) | QUINOLINECARBOXYLIC ACID DERIVATIVES | |
HUP0104058A2 (hu) | N-diszubsztituált piperazin vagy 1,4 diszubsztituált piperidin heterociklusos származékai és ezeket tartalmazó gyógyászati készítmények | |
SE8301412D0 (sv) | Substituerade 1h-pyrazolo(1,5)pyrimidiner och forfarande for deras framstellning | |
HUP0401883A2 (hu) | Muszkarin agonisták és ezeket tartalmazó gyógyászati készítmények | |
HUP9903758A2 (hu) | Benzoxazinon dopamin D4 receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0203187A2 (hu) | Izoxazolszármazékok mint foszfodiészteráz VII inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
MY140653A (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
HUP0201863A2 (hu) | Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
PT1161424E (pt) | Novos derivados de diazole como agentes serotonergicos | |
YU16196A (sh) | Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka | |
HUP0204149A2 (hu) | Új szulfoniloxazolamin-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására | |
TR200103286T2 (tr) | Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri | |
HUP0203696A2 (hu) | Sejtburjánzásgátló hatású helyettesített bisz-indolil-maleimidek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0402388A2 (hu) | N-(indolkarbonil-)piperazin-származékok alkalmazása gyógyszerkészítmények előállítására | |
ATE333870T1 (de) | Blockade der natriumkanäle durch phenolderivate |